Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sterilis

Explore full profile

Innovative medical waste company

Boxborough, United StatesFounded 2011Health Tech & Medtech
Valuation $5–10M Last recorded · 2016
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Sterilis and the history behind them.

About Sterilis

Sterilis Solutions, LLC is a privately held company that provides an on-site, on-demand solution for treating regulated medical waste (RMW). The company was founded in 2011, with the initial concept for its technology imagined in 2013 and developed over the subsequent five years. Headquartered in Chicago, Illinois, with operations and manufacturing in Boxborough and Springfield, Massachusetts, the company is led by CEO Andy Marshall.

The core of the company's offering is the patented Sterilis Solutions Remediator, a system that combines steam sterilization with a grinder to treat biohazardous materials. This process uses high-pressure steam to sterilize items like sharps containers, needles, syringes, and lab cultures, followed by grinding, which reduces the waste volume by as much as 80%. The resulting inert, confetti-like material can be disposed of in the regular municipal waste stream, offering a significant departure from the traditional haul-and-incinerate model. A full cycle takes approximately 60 minutes.

Sterilis Solutions targets a broad client base, including hospitals, surgical centers, clinics, laboratories, pharmacies, public safety departments, and airports. The business model centers on providing the Remediator system as a fixed-cost alternative to variable third-party hauling contracts, which are subject to annual price increases. This allows clients to manage costs, reduce liability, and improve environmental sustainability by eliminating the need for transportation and incineration of hazardous waste. The system features an integrated, cloud-based software that automatically logs compliance data and generates reports to meet state EPA standards, simplifying the administrative burden for clients.

In April 2024, Sterilis Solutions announced a strategic partnership with Polycarbin, a company focused on creating a circular economy for laboratory plastics. This collaboration enables customers to not only treat their medical waste on-site but also to have the resulting material enter a recycling stream, where it can be transformed into new laboratory products. This alliance enhances the company's value proposition by creating a closed-loop system for clients in the life sciences, pharmaceutical, and clinical diagnostics sectors.

Source: Dealroom company data

At a glance

Founded
2011
Headquarters
Boxborough, United States
Sector
Health Tech & Medtech

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Wasson Enterprise
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Boxborough HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sterilis on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sterilis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.